BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 30247650)

  • 1. Risk Factors Associated with Clostridium difficile Infection in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis.
    Balram B; Battat R; Al-Khoury A; D'Aoust J; Afif W; Bitton A; Lakatos PL; Bessissow T
    J Crohns Colitis; 2019 Jan; 13(1):27-38. PubMed ID: 30247650
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systematic review with meta-analysis: the impact of Clostridium difficile infection on the short- and long-term risks of colectomy in inflammatory bowel disease.
    Law CC; Tariq R; Khanna S; Murthy S; McCurdy JD
    Aliment Pharmacol Ther; 2017 Apr; 45(8):1011-1020. PubMed ID: 28206678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clostridium difficile Infection and Risk of Colectomy in Patients with Inflammatory Bowel Disease: A Bias-adjusted Meta-analysis.
    Chen Y; Furuya-Kanamori L; Doi SA; Ananthakrishnan AN; Kirk M
    Inflamm Bowel Dis; 2017 Feb; 23(2):200-207. PubMed ID: 28079620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Colon Surgery Risk With Corticosteroids Versus Immunomodulators or Biologics in Inflammatory Bowel Disease Patients With Clostridium difficile Infection.
    Solanky D; Pardi DS; Loftus EV; Khanna S
    Inflamm Bowel Dis; 2019 Feb; 25(3):610-619. PubMed ID: 30260451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors for Clostridioides difficile infection in children and adolescents with inflammatory bowel disease: a systematic review and meta-analysis.
    Fang SB; Song YQ; Zhang CY; Wang LB
    World J Pediatr; 2022 Jan; 18(1):27-36. PubMed ID: 34800281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clostridium difficile and inflammatory bowel disease: role in pathogenesis and implications in treatment.
    Nitzan O; Elias M; Chazan B; Raz R; Saliba W
    World J Gastroenterol; 2013 Nov; 19(43):7577-85. PubMed ID: 24282348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Higher Incidence of Clostridium difficile Infection Among Individuals With Inflammatory Bowel Disease.
    Singh H; Nugent Z; Yu BN; Lix LM; Targownik LE; Bernstein CN
    Gastroenterology; 2017 Aug; 153(2):430-438.e2. PubMed ID: 28479377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clostridium difficile infection and inflammatory bowel disease: understanding the evolving relationship.
    Navaneethan U; Venkatesh PG; Shen B
    World J Gastroenterol; 2010 Oct; 16(39):4892-904. PubMed ID: 20954275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clostridium Difficile Infection from a Surgical Perspective.
    Kaiser AM; Hogen R; Bordeianou L; Alavi K; Wise PE; Sudan R;
    J Gastrointest Surg; 2015 Jul; 19(7):1363-77. PubMed ID: 25917533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recurrence of Clostridium difficile Infection in Patients with Inflammatory Bowel Disease: The RECIDIVISM Study.
    Razik R; Rumman A; Bahreini Z; McGeer A; Nguyen GC
    Am J Gastroenterol; 2016 Aug; 111(8):1141-6. PubMed ID: 27215924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Obesity Is Associated with Increased Risk of Colectomy in Inflammatory Bowel Disease Patients Hospitalized with Clostridium difficile Infection.
    Shrestha MP; Taleban S
    Dig Dis Sci; 2019 Jun; 64(6):1632-1639. PubMed ID: 30569334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased Rates of Clostridium difficile Infection and Poor Outcomes in Patients with IBD with Cytomegalovirus.
    McCurdy JD; Enders FT; Khanna S; Bruining DH; Jones A; Killian JM; Tariq R; Smyrk TC; Loftus EV
    Inflamm Bowel Dis; 2016 Nov; 22(11):2688-2693. PubMed ID: 27755270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of severe outcomes associated with Clostridium difficile infection in patients with inflammatory bowel disease.
    Ananthakrishnan AN; Guzman-Perez R; Gainer V; Cai T; Churchill S; Kohane I; Plenge RM; Murphy S
    Aliment Pharmacol Ther; 2012 Apr; 35(7):789-95. PubMed ID: 22360370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clostridium difficile infection in patients with inflammatory bowel disease: a case control study.
    Vitikainen K; Haapamäki J; Färkkilä M; Anttila VJ; Arkkila P
    Scand J Gastroenterol; 2018 Aug; 53(8):947-951. PubMed ID: 30041549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of Faecal Microbiota Transplantation for Treatment of Clostridium difficile Infection in Patients With Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis of Cohort Studies.
    Chen T; Zhou Q; Zhang D; Jiang F; Wu J; Zhou JY; Zheng X; Chen YG
    J Crohns Colitis; 2018 May; 12(6):710-717. PubMed ID: 29528385
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Prevalence and Risk Factors of
    Song EM; Choi A; Kim S; Jung SH
    J Korean Med Sci; 2023 Dec; 38(47):e359. PubMed ID: 38050911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of Clostridium difficile infection on inflammatory bowel disease outcome: a review.
    Trifan A; Stanciu C; Stoica O; Girleanu I; Cojocariu C
    World J Gastroenterol; 2014 Sep; 20(33):11736-42. PubMed ID: 25206277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of Inclusion of Oral Antibiotics with Mechanical Bowel Preparation on the Risk of Clostridium Difficile Infection After Colectomy.
    Al-Mazrou AM; Hyde LZ; Suradkar K; Kiran RP
    J Gastrointest Surg; 2018 Nov; 22(11):1968-1975. PubMed ID: 29967968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clostridioides difficile Infection in Children With Inflammatory Bowel Disease.
    Chandrakumar A; Zohni H; El-Matary W
    Inflamm Bowel Dis; 2020 Oct; 26(11):1700-1706. PubMed ID: 31765471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic Modality of Clostridioides difficile Infection Predicts Treatment Response and Outcomes in Inflammatory Bowel Disease.
    Gupta A; Wash C; Wu Y; Sorrentino D; Nguyen VQ
    Dig Dis Sci; 2021 Feb; 66(2):547-553. PubMed ID: 32207033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.